Barclays Starts Abbvie (ABBV) at Equalweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- L3Harris CEO steps down amid conduct review, shares drop
- S&P 500 inches lower as Middle East tensions outweigh tech gains
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Deutsche Bank Downgrades Abbott Labs (ABT) to Hold to Reflect 'new ABT'
January 4, 2013 7:09 AM ESTDeutsche Bank downgraded Abbott Labs (NYSE: ABT) from Buy to Hold with a price target of $33.00 (from $70.00) following real-way trading of newly spun AbbVie (NYSE: ABBV)
The firm comments, "With this note, we are establishing our... More
BofA/Merrill Lynch Starts Abbvie (ABBV) at Buy
January 4, 2013 6:44 AM ESTBofA/Merrill Lynch initiates coverage on Abbvie (NYSE: ABBV) with a Buy. PT $40.00.
For an analyst ratings summary and ratings history on Abbvie click here. For more ratings news on Abbvie click here.
Shares of Abbvie closed at $34.83 yesterday, with a 52 week range of $34.10-$35.40.... More
JPMorgan Starts Abbvie (ABBV) at Overweight
January 2, 2013 7:36 AM ESTJPMorgan initiates coverage on Abbvie (NYSE: ABBV) with a Overweight. PT $38.00.
For an analyst ratings summary and ratings history on Abbvie click here. For more ratings news on Abbvie click here.
Shares of Abbvie closed at $ yesterday, with a 52 week range of $-$.... More
BMO Capital Starts Abbvie (ABBV) at Outperform
January 2, 2013 7:36 AM ESTBMO Capital initiates coverage on Abbvie (NYSE: ABBV) with a Outperform. PT $39.00.
For an analyst ratings summary and ratings history on Abbvie click here. For more ratings news on Abbvie click here.
Shares of Abbvie closed at $ yesterday, with a 52 week range of $-$.... More
